Invesco Nasdaq Biotech UCITS ETF

ISIN IE00BQ70R696

 | 

Ticker SBIO

TER
0.40% p.a.
Distribution policy
Accumulating
Replication
Swap-based
Fund size
252 m
 

Overview

Description

The Invesco Nasdaq Biotech UCITS ETF seeks to track the Nasdaq Biotechnology index. The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease.
 
The ETF's TER (total expense ratio) amounts to 0.40% p.a.. The ETF replicates the performance of the underlying index synthetically with a swap. The dividends in the ETF are accumulated and reinvested in the ETF.
 
The Invesco Nasdaq Biotech UCITS ETF has 252m GBP assets under management. The ETF was launched on 6 November 2014 and is domiciled in Ireland.
Show more Show less

Chart

Basics

Data

Index
Nasdaq Biotechnology
Investment focus
Equity, United States, Health Care
Fund size
GBP 252 m
Total expense ratio
0.40% p.a.
Replication Synthetic (Unfunded swap)
Legal structure ETF
Strategy risk Long-only
Sustainability No
Fund currency USD
Currency risk Currency unhedged
Volatility 1 year (in GBP)
18.43%
Inception/ Listing Date 6 November 2014
Distribution policy Accumulating
Distribution frequency -
Fund domicile Ireland
Fund Provider Invesco
Germany 30% tax rebate
Switzerland ESTV Reporting
Austria Tax Reporting Fund
UK UK Reporting
Indextype Total return index
Swap counterparty Goldman Sachs|J.P. Morgan|Morgan Stanley
Collateral manager
Securities lending No
Securities lending counterparty

Similar ETFs

This section provides you with information on other ETFs with a similar investment focus to the Invesco Nasdaq Biotech UCITS ETF.
Similar ETFs via ETF search
How do you like our ETF profile? Here you'll find our Questionnaire.

Performance

Returns overview

YTD +6.14%
1 month +0.08%
3 months -2.16%
6 months +5.17%
1 year +17.43%
3 years +4.29%
5 years +28.71%
Since inception (MAX) +93.13%
2023 -1.50%
2022 +0.33%
2021 +0.93%
2020 +21.82%

Monthly returns in a heat map

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 18.43%
Volatility 3 years 23.08%
Volatility 5 years 25.42%
Return per risk 1 year 0.94
Return per risk 3 years 0.06
Return per risk 5 years 0.20
Maximum drawdown 1 year -10.13%
Maximum drawdown 3 years -24.46%
Maximum drawdown 5 years -30.71%
Maximum drawdown since inception -33.80%

Rolling 1 year volatility

Stock exchange

Listings

Listing Trade Currency Ticker Bloomberg /
iNAV Bloomberg Code
Reuters RIC /
iNAV Reuters
Market Maker
gettex EUR NBTK -
-
-
-
-
Borsa Italiana USD - SBIO IM
SBIOINE
SBIO.MI
0J1KINAV.DE
Commerzbank
KCG
Borsa Italiana EUR SBIO SBIO IM
SBIOINE
SBIO.MI
0J1KINAV.DE
Commerzbank
KCG
Euronext Amsterdam EUR SBIO SBIO NA
SBIOINE
SBIO.AS
0J1JINAV.DE
Commerzbank
KCG
London Stock Exchange USD SBIO SBIO LN
SBIOIN
SBIO.L
0J1KINAV.DE
Commerzbank
KCG
SIX Swiss Exchange USD SBIO SBIO SW
SBIOIN
SBIO.S
0J1KINAV.DE
Commerzbank
KCG
XETRA EUR NBTK NBTK GR
SBIOINE
NBTKG.DE
0J1JINAV.DE
Commerzbank
KCG

Further information

Further ETFs on the Nasdaq Biotechnology index

Fund name Fund Size in m € (AuM) TER p.a. Distribution Replication
iShares Nasdaq US Biotechnology UCITS ETF 465 0.35% p.a. Accumulating Sampling
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 34 0.35% p.a. Distributing Sampling

Frequently asked questions

What is the name of SBIO?

The name of SBIO is Invesco Nasdaq Biotech UCITS ETF.

What is the ticker of Invesco Nasdaq Biotech UCITS ETF?

The primary ticker of Invesco Nasdaq Biotech UCITS ETF is SBIO.

What is the ISIN of Invesco Nasdaq Biotech UCITS ETF?

The ISIN of Invesco Nasdaq Biotech UCITS ETF is IE00BQ70R696.

What are the costs of Invesco Nasdaq Biotech UCITS ETF?

The total expense ratio (TER) of Invesco Nasdaq Biotech UCITS ETF amounts to 0.40% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.

Is Invesco Nasdaq Biotech UCITS ETF paying dividends?

Invesco Nasdaq Biotech UCITS ETF is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.

What's the fund size of Invesco Nasdaq Biotech UCITS ETF?

The fund size of Invesco Nasdaq Biotech UCITS ETF is 252m GBP. See the following article for more information about the size of ETFs.

Track your ETF strategies online

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.